Cencora (COR) News
NYSE: CORHealth CareOther PharmaceuticalsUSD
323.85+2.50 (+0.78%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
COR news summary
We found 32 recent headlines mentioning Cencora (COR): 1 in the past week and 13 in the past 30 days, most often from Nasdaq, Seeking Alpha. For price context, COR is up 0.78% at $323.85. The most recent story, "Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs Grow", was published by Seeking Alpha on Oct 6, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Cencora headlines
- Cencora Remains A Buy At These Prices, As Healthcare Supply-Chain Needs GrowSeeking Alpha
- Invesco S&P 500 Revenue ETF Experiences Big OutflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an…NasdaqRWL, MCK, CVS, COR
- Here's Why Cencora (COR) is a Strong Growth StockWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.Nasdaq
- Notable ETF Inflow Detected - RWL, MCK, COR, CILooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Invesco S&P 500 Revenue ETF (Symbol: RWL) where we have detected an…NasdaqRWL, MCK, COR, CI
- Can CAH's MSO Expansion Unlock Growth in Specialty Care Delivery?CAH is expanding its MSO strategy across specialty care, with Solaris and broader services aimed at scaling physician networks.NasdaqCAH, MCK, COR
- Cencora Sees Specialty Strategy Fueling Growth Into Fiscal 2027Cardinal Health Earnings: Can Perfection Get Priced In Twice?Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing…Nasdaq
- Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at ConferenceCardinal Health Earnings: Can Perfection Get Priced In Twice?Cencora (NYSE:COR) executives highlighted the company’s specialty pharmaceutical positioning, medical specialty organization…Nasdaq
- Here's Why Cencora (COR) is a Strong Value StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.Nasdaq
- Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference TranscriptSeeking Alpha
- Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking AlphaCOR, MS
- CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?Cardinal Health's 29% rally reflects stronger specialty growth, MSO expansion and higher-margin assets, but cost pressures could test the uptrend.NasdaqCAH, MCK, COR
- TCAF, CNP, COR, ALNY: ETF Inflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we…NasdaqTCAF, CNP, COR, ALNY
- Here's Why Cencora (COR) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.Nasdaq
- Cencora, Inc. (COR) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha
- Why Cencora (COR) is a Top Growth Stock for the Long-TermThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.Nasdaq
- Here's Why You Should Retain Cencora Stock in Your Portfolio for NowCencora's specialty momentum, OneOncology growth and GLP-1 volumes offer upside, but drug-price cuts and MWI risks cloud its outlook.NasdaqCOR, WST, GMED, VCYT
- Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?Cencora (COR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.NasdaqCOR, MD
- Cencora Launches Cell and Gene Therapy Enablement for Health SystemsCOR launches CGT Enablement to help health systems build and scale cell and gene therapy programs with financial, operational and access support.NasdaqCOR, WST, GMED, VCYT
- Cencora Raises 2026 EPS Outlook as Specialty Businesses StrengthenCencora raised its fiscal 2026 EPS outlook as specialty businesses fueled stronger profit growth despite mix, pricing and financing pressures.NasdaqCOR, CAH, MCK
- Targa Resources Moves Up In Market Cap Rank, Passing CencoraIn the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Targa Resources Corp (Symbol: TRGP) has taken over the #192 spot from Cencora Inc (Symbol:…NasdaqTRGP, COR
- Cardinal Health a new outperform at RBC on higher margin servicesSeeking AlphaCOR, CAH
- Cencora, Inc. (COR) Q3 2026 Earnings Call TranscriptSeeking Alpha
- Cencora, Inc. 2026 Q3 - Results - Earnings Call PresentationSeeking Alpha
- Cencora: Specialty Infrastructure Is Rewriting The Distributor ModelSeeking Alpha
- Cencora, Inc. (COR) Presents at BofA Securities 2026 China Conference TranscriptSeeking Alpha
- Cencora, Inc. (COR) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking AlphaCOR, BAC
- Cencora Earnings Review: The Selloff Was Overdone In My ViewSeeking Alpha
- Cencora, Inc. (COR) Q2 2026 Earnings Call TranscriptSeeking Alpha
- Cencora, Inc. 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha
- All Eyes On Cencora, A Healthcare Supplier That Could See Lots More UpsideSeeking Alpha
- Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 TranscriptSeeking Alpha
- The Best Growth Dividend Stocks of 2015Source: General Electric Company Growth dividend stocks can often be the best of both worlds-they deliver investors cash today with the promise of.NasdaqCCZ, AMZN, GE, CSCO